These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 22235621

  • 21. Epidemiological characteristics of leprosy reactions: 15 years experience from north India.
    Kumar B, Dogra S, Kaur I.
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):125-33. PubMed ID: 15301592
    [Abstract] [Full Text] [Related]

  • 22. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
    Shaw IN, Ebenezer G, Rao GS, Natrajan MM, Balasundaram B.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
    [Abstract] [Full Text] [Related]

  • 23. Short-term follow up of patients with multibacillary leprosy and HIV infection.
    Jacob M, George S, Pulimood S, Nathan N.
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):392-5. PubMed ID: 9030104
    [Abstract] [Full Text] [Related]

  • 24. Changes in the size and number of skin lesions in PB leprosy on treatment and follow-up.
    Rao PN, Suneetha S, Pratap DV.
    Lepr Rev; 2011 Sep; 82(3):244-52. PubMed ID: 22125932
    [Abstract] [Full Text] [Related]

  • 25. Ocular hypotension and hypotony in multibacillary leprosy patients; at diagnosis, during and after completion of multidrug therapy.
    Daniel E, Rao PS, Ffytche TJ, Courtright P.
    Indian J Lepr; 2010 Sep; 82(4):181-8. PubMed ID: 21434594
    [Abstract] [Full Text] [Related]

  • 26. [Estimation of the execution of the national strategy of leprosy elimination in the "Hauts Bassins" region in Burkina Faso].
    Diallo B, Barro Traoré F, Andonaba JB, Tapsoba P, Sawadogo G, Traoré A.
    Mali Med; 2012 Sep; 27(1):27-32. PubMed ID: 22773078
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of fixed duration multidrug therapy for the treatment of multibacillary leprosy: A prospective observational study from Northern India.
    Singh I, Ahuja M, Lavania M, Pathak VK, Turankar RP, Singh V, Sengupta U, Das L, Kumar A, Saini GB.
    Indian J Dermatol Venereol Leprol; 2023 Sep; 89(2):226-232. PubMed ID: 36331863
    [Abstract] [Full Text] [Related]

  • 28. Histoid, a clinical variant of multibacillary leprosy: report from so-called nonendemic areas.
    Kalla G, Purohit S, Vyas MC.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):267-71. PubMed ID: 11221088
    [Abstract] [Full Text] [Related]

  • 29. Multibacillary leprosy: erythema as the only clinical presentation.
    Wen PF, Wang L.
    Chin Med J (Engl); 2012 Feb; 125(3):558-60. PubMed ID: 22490424
    [Abstract] [Full Text] [Related]

  • 30. Leprosy beyond MDT: study of follow-up of 100 released from treatment cases.
    Vara N, Agrawal M, Marfatia Y.
    Indian J Lepr; 2010 Feb; 82(4):189-94. PubMed ID: 21434595
    [Abstract] [Full Text] [Related]

  • 31. Treatment of histoid leprosy: a lack of consensus.
    Bartos G, Sheuring R, Combs A, Rivlin D.
    Int J Dermatol; 2020 Oct; 59(10):1264-1269. PubMed ID: 32544270
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Leprosy in transplant recipients: report of a case after liver transplantation and review of the literature.
    Trindade MA, Palermo ML, Pagliari C, Valente N, Naafs B, Massarollo PC, D'Albuquerque LA, Benard G.
    Transpl Infect Dis; 2011 Feb; 13(1):63-9. PubMed ID: 20678090
    [Abstract] [Full Text] [Related]

  • 35. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M, Berhe D.
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [Abstract] [Full Text] [Related]

  • 36. Longitudinal ocular survey of 202 Filipino patients with multi-bacillary (MB) leprosy treated with 2 year WHO-multiple drug therapy.
    Ravanes JM, Cellona RV, Balagon M, Abalos RM, Walsh GP, Walsh DS.
    Southeast Asian J Trop Med Public Health; 2011 Mar; 42(2):323-30. PubMed ID: 21710853
    [Abstract] [Full Text] [Related]

  • 37. Relapses in multibacillary leprosy patients after multidrug therapy.
    Poojabylaiah M, Marne RB, Varikkodan R, Bala N, Dandakeri S, Martis J.
    Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.